Cargando…

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes

BACKGROUND: The presence of fibrosis is a criterion for subtype classification in the newly updated hypersensitivity pneumonitis (HP) guidelines. The present study aimed to summarize differences in clinical characteristics and prognosis of non-fibrotic hypersensitivity pneumonitis (NFHP) and fibroti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xueying, Yang, Xiaoyan, Ren, Yanhong, Xie, Bingbing, Xie, Sheng, Zhao, Ling, Wang, Shiyao, Geng, Jing, Jiang, Dingyuan, Luo, Sa, He, Jiarui, Shu, Shi, Hu, Yinan, Zhu, Lili, Li, Zhen, Zhang, Xinran, Liu, Min, Dai, Huaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686610/ https://www.ncbi.nlm.nih.gov/pubmed/37464421 http://dx.doi.org/10.1097/CM9.0000000000002613

Ejemplares similares

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Features of transbronchial lung cryobiopsy‐diagnosed fibrotic hypersensitivity pneumonitis
por: Zhan, Xi, et al.
Publicado: (2022)

Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017)

Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis
por: Nishida, Takashi, et al.
Publicado: (2021)

Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
por: Kang, Jieun, et al.
Publicado: (2021)

Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?
por: Pereira, João O., et al.
Publicado: (2023)

Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis
por: Oh, Ju Hyun, et al.
Publicado: (2023)

Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
por: Okuda, Ryo, et al.
Publicado: (2022)

Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort
por: Seixas, E, et al.
Publicado: (2022)

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
por: Okuda, Ryo, et al.
Publicado: (2023)

Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis
por: Wang, Junyi, et al.
Publicado: (2022)

Dyskeratosis congenita with heterozygous RTEL1 mutations presenting with fibrotic hypersensitivity pneumonitis
por: Han, Jinhee, et al.
Publicado: (2023)

Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients: relationship to disease activity and the fibrotic radiographic phenotype
por: Zhang, Hui, et al.
Publicado: (2023)

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study
por: Guler, Sabina A., et al.
Publicado: (2021)

Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches
por: Moua, Teng, et al.
Publicado: (2022)

Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis
por: Macaluso, Claudio, et al.
Publicado: (2022)

Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration
por: Moda, Mitsuhiro, et al.
Publicado: (2022)

Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort
por: Mendonça Almeida, Leonor, et al.
Publicado: (2022)

Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis
por: Adams, Traci N., et al.
Publicado: (2023)

Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis
por: Ejima, Masaru, et al.
Publicado: (2021)

High-resolution computed tomography features of asbestosis versus fibrotic hypersensitivity pneumonitis: an observational study
por: Ma, Ruimin, et al.
Publicado: (2022)

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
por: Tzilas, Vasilios, et al.
Publicado: (2020)

Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
por: Fernández Pérez, Evans R., et al.
Publicado: (2021)

Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis
por: Takimoto, Takayuki, et al.
Publicado: (2022)

Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis
por: Ito, Yasuhiro, et al.
Publicado: (2022)

Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Sobiecka, Małgorzata, et al.
Publicado: (2023)

The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study
por: Okabayashi, Hiroko, et al.
Publicado: (2022)

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated bronchioloalveolar disorder required differentiation from fibrotic chronic hypersensitivity pneumonitis
por: Chikasue, Tomonori, et al.
Publicado: (2022)

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue
por: Xu, Xuefeng, et al.
Publicado: (2020)

Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
por: Giannoni, Paolo, et al.
Publicado: (2021)

Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study
por: Barratt, Shaney L, et al.
Publicado: (2021)

A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
por: Fan, Mingming, et al.
Publicado: (2022)

Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
por: Vanderstichele, Sophie, et al.
Publicado: (2022)

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
por: Fan, Mingming, et al.
Publicado: (2023)

Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
por: Fan, Mingming, et al.
Publicado: (2023)

Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis
por: Jiang, Dingyuan, et al.
Publicado: (2022)

Occupational fibrotic hypersensitivity pneumonia in a halogen dishes manufacturer: A case report
por: Wang, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gahefnpt6f2l5nl6oup32sf1nj